OpenAI's GPT-4 correctly diagnosed 52.7% of complex challenge cases, compared to 36% of medical journal readers, and outperformed 99.98% of simulated human readers, according to a study published by the New England Journal of Medicine.
The evaluation, conducted by researchers in Denmark, utilized GPT-4 to find diagnoses pertaining to 38 complex clinical case challenges with text information...
Medical technology firm Artrya has been cleared by the Australian government to commercialise an AI tool that diagnoses coronary heart disease. It has partnered with Perth-based radiology practice Envision Medical Imaging to market the product by early next year.
WHAT IT'S ABOUT
The AI tool,Salix, has been developed through the collaboration of researchers from the University of Western Australia...
Endimension, a health AI startup from India, has raised 23 million rupees (over $300,000) in seed funding from one of the country's largest angel investors, Inflection Point Ventures.
WHAT IT DOES
The startup was incubated at the Indian Institute of Technology Bombay in 2018. It develops AI algorithms to automatically detect abnormalities and diseases from medical scans. Its AI platform called...
Palo Alto, California-based AI diagnostic maker Pr3vent, Inc. has closed a Series A funding round led by InFocus Capital Partners. While Pr3vent did not disclose the investment amount in its announcement, MedCityNews pegs the round at $1.5 million.
The latest fundraising comes hot off of the heels of Pr3vent’s seed round, which raised $1 million back in October.
What they do
Pr3vent is building...
Last week New York-based, AI-powered cancer screening platform Ezra announced that it scored $4 million in a seed funding led by Accomplice, with additional funding from Founders Future, Credo Ventures, Seedcamp, Esther Dyson and various unnamed startup founders and angel investors.
This funding announcement is paired with the beta launch of its prostate cancer screening program. Right now the...
Artificial intelligence medical imaging diagnostics startup Visla Labs announced today that it has raised $3 million in seed funding. The round was led by Lux Capital, with participation from others including Dick Costolo and Adam Bain, Twitter’s former CEO and COO, respectively.
The startup’s first software offering uses AI to increase the accuracy, speed and cost of radiology diagnoses. Founded...
What happened
IDx, maker of autonomous AI diagnostic tool for diabetic retinopathy, has landed $33 million in Series A financing. This comes just months after its IDx-DR got the designation as the first FDA-cleared autonomous AI diagnostic system. The latest funding was led by 8VC with participation from Optum Ventures, Alpha Edison, and Heritage Provider Network.
Why it matters
Now the company...
What happened
This morning digital pathology startup Proscia announced that it closed a $8.3 million Series A funding round. The financing was led by Flybridge Capital Partners with participation from Emerald Development Managers, Fusion Fund, Razor’s Edge Ventures and RobinHood Ventures.
The impact
The Philadelphia-base startup plans to use the new money to commercialize its digital pathology...
A hybrid system combining artificial intelligence with live human specialists was able to more effective diagnose pneumonia from chest X-rays than a previously validated automatic diagnostic algorithm, according to data presented this week at the 2018 SIIM Conference on Machine Intelligence in Medical Imaging.
The study, conducted by researchers from Stanford University School of Medicine and...
